{
 "drug": "Iron Sucrose Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "05/21/2026",
 "dayN": 96,
 "cat": "Hematology",
 "companies": [
  "Mylan Institutional, a Viatris Company"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "05/21/2026",
   "update_type": "New",
   "initial_posting_date": "05/21/2026",
   "package_ndc": "67457-957-99",
   "generic_name": "Iron Sucrose Injection",
   "contact_info": "800-796-9526",
   "related_info": "A business decision has been made to discontinue of 2.5mL presentation only. Continuity of supply is forecasted across all other presentations of Iron Sucrose: 67457-639-10 Iron Sucrose 20mg/mL 10mL SDV 5PK 67457-638-10 Iron Sucrose 20mg/mL 5mL SDV 10PK 67457-638-25 Iron Sucrose 20mg/mL 5mL SDV 25PK.",
   "openfda": {
    "application_number": [
     "ANDA212559"
    ],
    "brand_name": [
     "IRON SUCROSE"
    ],
    "generic_name": [
     "IRON SUCROSE"
    ],
    "manufacturer_name": [
     "Mylan Institutional LLC"
    ],
    "product_ndc": [
     "67457-957",
     "67457-638",
     "67457-639"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "IRON SUCROSE"
    ],
    "rxcui": [
     "1741261",
     "1741267",
     "1741270"
    ],
    "spl_id": [
     "3f109bdb-a412-43b2-84c7-9dad05e85a71"
    ],
    "spl_set_id": [
     "3f109bdb-a412-43b2-84c7-9dad05e85a71"
    ],
    "package_ndc": [
     "67457-957-00",
     "67457-957-99",
     "67457-957-25",
     "67457-638-00",
     "67457-638-10",
     "67457-638-25",
     "67457-639-00",
     "67457-639-10",
     "67457-639-99"
    ],
    "nui": [
     "M0011718",
     "N0000177913"
    ],
    "pharm_class_cs": [
     "Iron [CS]"
    ],
    "pharm_class_epc": [
     "Parenteral Iron Replacement [EPC]"
    ],
    "unii": [
     "FZ7NYF5N8L"
    ]
   },
   "update_date": "05/21/2026",
   "therapeutic_category": [
    "Hematology"
   ],
   "dosage_form": "Injection",
   "presentation": "Iron Sucrose, Injection, 50 mg/2.5 mL (NDC 67457-957-99)",
   "company_name": "Mylan Institutional, a Viatris Company",
   "status": "To Be Discontinued"
  }
 ]
}